Significance of serum 8-Hydroxydeoxyguanosine levels to the intima-media thickness of the carotid artery in type 2 diabetes

Yan Lu 1 , Yiqun Lu 1 , Xingbo Cheng 2 , Huijuan Li 1 ,  and Yafeng Zhou 3
  • 1 Department of Endocrinology and Metabolism, Suzhou City, Jiangsu 215006, China
  • 2 Department of Endocrinology and Metabolissm, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China
  • 3 Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu 215006, China

Abstract

Background: Cardiovascular disease is the largest cause of morbidity and mortality in patients with type 2 diabetes mellitus. Interestingly, previous studies demonstrated that type 2 diabetic patients had a significantly higher concentration of 8-Hydroxydeoxyguanosine (8-OHdG) although it role in the pathogenesis of carotid artery atheroma and insulin resistance has not been identified.

Objective: We investigated the role of serum 8-OHdG levels in the intima-media thickness (IMT) of the carotid artery, and its significance in insulin resistance in type 2 diabetes.

Methods: Fifty patients with disease-onset type 2 diabetes were enrolled and divided into two groups according to the intima-media thickness of the carotid artery (<1.0 mm = group A or ≥1.0 mm = group B). Blood samples from patients were used within one month for the determination of 8-OHdG using a competitive ELISA kit, and other coronary heart disease (CHD) risk factors were also measured.

Results: Patients in Group B showed significant higher levels of serum 8-OHdG compared to that of group A and control. Serum 8-OHdG had significant positive correlations with BMI, SBP, FPG, FINS, HbA1c, TC, and Homa-IR. Similarly, a significant positive correlation existed between the serum 8-OHdG and IMT levels. 8-OHdG, Homa-IR, HbA1c and TC were independently associated with increased IMT in type 2 diabetes patients.

Conclusion: Serum 8-OHdG is a useful indicator for the severity of IMT of the carotid artery and reflects the severity of insulin resistance in type 2 diabetes.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Maxwell CS, Wood RJ. Update on vitamin D and type 2 diabetes. Nutr Rev. 2011; 69:291-5.

    • Crossref
    • Export Citation
  • 2. Unger J, Parkin CG. Type 2 diabetes: an expanded view of pathophysiology and therapy. Postgrad Med. 2010; 122:145-57.

    • Crossref
    • Export Citation
  • 3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339:229-34.

  • 4. Reaven GM. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarties and differences. J Clin Hypertens (Greenwich). 2011; 13:238-43.

    • Crossref
    • Export Citation
  • 5. Bloomgarden ZT. World congress on insulin resistance, diabetes and cardiovascular disease: part 2. Diabetes Care. 2011; 34:e126-31.

  • 6. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, et al. New biomarker evidence of oxidative DNA damage in patients with non-insulindependent diabetes mellitus. FEBS Lett. 1997; 417: 150-2.

  • 7. Loft S, Fischer-Nielsen A, Jeding IB, Vistisen K, Poulsen HE. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J Toxicol Environ Health. 1993; 40:391-404.

    • Crossref
    • Export Citation
  • 8. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, et al. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996; 347:444-5.

  • 9. Krapfenbauer K, Birnbacher R, Vierhapper H, Herkner K, Kampel D, Lubec G. Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus. Clin Sci (Lond). 1998; 95:331-7.

    • Crossref
    • Export Citation
  • 10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15:539-53.

    • Crossref
    • Export Citation
  • 11. Kitamura A, Iso H, Imano H, Ohira T, Okada T, Sato S, et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004; 35:2788-94.

    • Crossref
    • Export Citation
  • 12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-9.

    • Crossref
    • Export Citation
  • 13. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002; 23:599-622.

    • Crossref
    • Export Citation
  • 14. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stressactivated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes. 2003; 52:1-8.

    • Crossref
    • Export Citation
  • 15. Nourooz Nourooz-Zadeh J, Rahimi A, Tajaddini- Sarmadi J, Tritschler H, Rosen P, Halliwell B, et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia. 1997; 40:647-53.

    • Crossref
    • Export Citation
  • 16. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008; 9:315-27.

    • Crossref
    • Export Citation
  • 17. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008; 57:1446-54.

    • Crossref
    • Export Citation
  • 18. Figueroa-Romero C, Sadid M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008; 9:301-14.

    • Crossref
    • Export Citation
  • 19. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the otterdam Study. Circulation. 1997; 96:1432-7.

    • Crossref
    • Export Citation
  • 20. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, Kamada T. Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care. 1992; 15:1290-4.

    • Crossref
    • Export Citation
  • 21. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-47.

    • Crossref
    • Export Citation
  • 22. Goldstein BJ, Mahadev K, Wu X, Zhu L, Motoshima H. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal. 2005; 7:1021-31.

  • 23. Shi Y, Patel S, Davenpeck KL, Niculescu R, Rodriguez E, Magno MG, et al. Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation. 2001; 103:2408-13.

    • Crossref
    • Export Citation
  • 24. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assesstent of IR in relation to the incidence of cardiovascular disease: the Sam Antonio Heart Study. Diabetes Care. 2002; 25:1177-84.

    • Crossref
    • Export Citation
OPEN ACCESS

Journal + Issues

Search